미용 임플란트 : 세계 시장 인사이트, 경쟁 구도 및 시장 예측(-2030년)

Aesthetic Implants Market By Product Type (Breast Implants, Body Contouring Implants, Custom-Made Implants, Nasal Implants, Dental Implants, And Others), By Gender (Male And Female), By End-User (Hospitals, Cosmetology Clinics, And Ambulatory Surgical Centers), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing prevalence of breast cancer and increase in number of cosmetic & reconstructive plastic surgeries

The global aesthetic implants market is estimated to grow at a CAGR of 7.82% during the forecast period from 2024 to 2030. The aesthetic implants market is witnessing positive growth owing to various factors such as the increasing prevalence of breast cancer, increase in the number of cosmetic & reconstructive surgeries, rise in the product launches related to aesthetic implants, and increasing need for attractive physical appearance. Therefore, the market for aesthetic implants is estimated to grow at a significant CAGR during the forecast period from 2024 to 2030.

Aesthetic Implants Market Dynamics:

One of the main drivers of the aesthetic implant market is the increasing prevalence of breast cancer globally. For instance, as per the World Health Organization (WHO) published data in the year 2023, in 2020, 2.3 million women were diagnosed with breast cancer throughout the world. According to the same source and statistics, across the world, 7.8 million women would have been diagnosed with breast cancer in the previous five years. Therefore, with the increasing global prevalence of breast cancer, the need for breast implants could also surge, driving the overall aesthetic implants market forward over the forecast period (2024-2030).

Moreover, another key factor that is responsible for the growth of the aesthetic implants market is the increase in the number of cosmetic & reconstructive surgeries. For instance, as per the plastic surgery statistics report in the year 2020, in America, out of 15.6 million cosmetic procedures, 2.3 million were cosmetic surgical procedures whereas 13.2 million procedures were minimally-invasive. According to the source mentioned above, in 2020, reconstructive procedures were 6.8 Million (a 3% increase from 2019). Additionally, as per the above-referenced source, in 2020, there were 193,073 breast augmentations, silicone implants accounting for 84% of all procedures, and saline implants accounting for 16%. Thus, an increase in the number of cosmetic & reconstructive surgeries will increase the demand for aesthetic implants, thereby propelling the growth of aesthetic implants' overall market.

Therefore, the factors stated above collectively will drive the aesthetic implants market during the forecast period from 2024-2030.

However, infections associated with the aesthetic implants and the high cost of aesthetic implants can hamper the global aesthetic implant market growth

The Coronavirus pandemic (COVID-19) has negatively impacted the market for aesthetic implants as hospital admissions were limited, as well as elective surgeries were not a priority in comparison to the patients suffering from COVID. Lockdown restrictions, lack of staff, and shortage of masks and PPE kits made a huge impact on patient admissions in hospitals for surgeries. However, with masses being vaccinated, lockdown restriction relaxation, resumption of elective surgeries, and availability of masks, PPE kits, and staff, with all these measures back on track the aesthetic implants market has picked momentum again and is expected to further grow during the forecast period from 2024-2030.

Aesthetic Implants Market Segment Analysis:

Aesthetic Implants Market by Product Type (Breast Implant, Body Contouring Implants, Custom-Made Implants, Nasal Implants, Dental Implants, and Others), Gender (Male and Female), End-User (Hospitals, Cosmetology Clinics, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In by product type segment of the dental implants market, is expected to share a significant revenue share in the year 2023. Benefits associated with dental implants are, as they are used to prevent bone loss, they act like natural teeth, the implants last a lifetime, they can be required to keep adjacent teeth stable, improve the appearance, oral health, self-esteem as well as speech, they are durable, help to get free from gum disease, help to prevent facial sagging & premature aging. Thus, these benefits associated with dental implants can increase the demand for aesthetic implants, which could drive the aesthetic implants' overall market growth.

However, various technologically advanced aesthetic implants receive approvals, this can also be expected to drive the overall market growth for aesthetic implants. For instance, in June 2022, Biotech Dental SAS, a designer and manufacturer of medical devices and digital solutions for dental surgeons, orthodontists, and dental prosthesis laboratories, received United States (US) Food and Drug Administration (FDA) approval for Kontact Dental Implant System, the implant system is designed to support single-unit, multiple-unit, or overdenture dental restorations in partly or completely edentulous patients.

Moreover, due to the interplay of all the factors mentioned above, this can result in the rising demand for aesthetic implants, which in turn would provide a conducive growth environment for the overall aesthetic implants market during the forecast period from 2024-2030.

North America is expected to dominate the overall Aesthetic Implants Market:

Among all the regions, North America is expected to dominate the global aesthetic implants market in the year 2023 and is expected to do the same during the forecast period from 2024-2030. Factors such as the increasing prevalence of breast cancer and the rise in product launches related to aesthetic implants are expected to increase the demand of aesthetic implants in the North America market.

According to the latest data published by the American Cancer Society in the year 2023, in the United States, one out of every eight women under the age of 45 will acquire invasive breast cancer by the end of the year 2022, and two out of every three invasive breast cancers will be diagnosed in women 55 and older. Thus, with the increasing prevalence of breast cancer, the need for breast implants could also surge, this can drive the overall aesthetic implants market forward over the forecast period (2024-2030).

Furthermore, another factor such as the rise in the product launches related to aesthetic implants could drive the aesthetic implant's overall market in the region. For instance, in February 2022, Merz Aesthetics, the world's largest dedicated medical aesthetics company, announced the commercial launch of Radiesse® (+) Lidocaine injectable implant, for deep injection (subdermal and/or supraperiosteal) in the United States for soft tissue augmentation to improve moderate to a severe loss of jawline contour in adults over the age of 21.

Therefore, the interplay of the aforementioned factors would provide a conducive growth environment for the North American region in the aesthetic implants market.

Aesthetic Implants Market Key Players:

Some of the key market players operating in the aesthetic implants market include POLYTECH Health & Aesthetics GmbH, Sientra, Inc, Surgiform Innovative Surgical Products, GC Aesthetics, Dentsply Sirona, Institut Straumann AG, AVINENT, AbbVie, Establishment Labs S.A., Mentor (Johnson & Johnson Medical Ltd), 3M, Zimmer Biomet, Alpha Aesthetics, Symatese, Integra LifeSciences, Sebbin, IDEAL IMPLANT INCORPORATED, Lattice Medical, CEREPLAS, Guangzhou Wanhe Plastic Material Co Ltd, and among others.

Recent Developmental Activities in the Aesthetic Implants:

In May 2022, GC Aesthetics®, Inc. (GCA), a privately-held medical technology company providing healthcare aesthetic solutions, announced the launch of an Innovative Nipple Areola Complex (NAC) Reconstruction Implant: FixNip(TM) NRI

In May 2022, GC Aesthetics, Inc., a privately-held medical technology company providing aesthetic solutions for global healthcare markets, announced the launch of its next generation of breast implants, PERLE(TM). It's a cutting-edge series of smooth breast implants with a proprietary surface technology (BioQ(TM)), GCA's industry-leading gel technology (EmunomicTM Breast Tissue Dynamic Gel), and an upgraded version of GCA's long-term great safety record

In November 2019, BellaSeno, a German additive manufacturing start-up & Evonik, a chemical company, BellaSeno, and Evonik have formed a long-term partnership to develop a new breast implant technology based on Evonik's RESOMER bioresorbable polymer. RESOMER will be used in BellaSeno's 3D-printed senella breast scaffold. The product is designed to be used after reconstruction, augmentation, or revision surgery. It is resorbed by the body and gradually replaced by natural breast tissue

Key Takeaways from the Aesthetic Implants Market Report Study:

• Market size analysis for current aesthetic implants market (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the aesthetic implants market
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
• Key companies dominating the global aesthetic implants market
• Various opportunities are available for the other competitor in the aesthetic implants market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030.
• Which is the top-performing regions and countries in the current aesthetic implants market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for aesthetic implant market growth in the coming future?

Target Audience who can be benefited from this Aesthetic Implants Market Report Study:

• Aesthetic implants providers
• Research organizations and consulting companies
• Aesthetic implants-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in aesthetic implants
• Various end-users who want to know more about the aesthetic implants market and the latest technological developments in the aesthetic implants

Frequently Asked Questions for Aesthetic Implants:

1. What are Aesthetic Implants?

Aesthetic implant placement is driven by both a restorative and biological philosophy. The implant is positioned to meet the contour requirements for a good repair and should be positioned biologically to allow for the preservation of both hard and soft tissue architecture.

2. What is the market for Global Aesthetic Implants?

The global aesthetic implants market is estimated to grow at a CAGR of 7.82% during the forecast period from 2024 to 2030.

3. What are the drivers for the Global Aesthetic implants market?

The Aesthetic implants market is witnessing positive market growth owing to the factors such as the increasing prevalence of breast cancer, increase in the number of cosmetic & reconstructive surgeries, rise in the product launches related to aesthetic implants, and increasing need for attractive physical appearance

4. Who are the key players operating in the Aesthetic implants market?

Some of the key market players operating in the Aesthetic implants market include POLYTECH Health & Aesthetics GmbH, Sientra, Inc, Surgiform Innovative Surgical Products, GC Aesthetics, Dentsply Sirona, Institut Straumann AG, AVINENT, AbbVie, Establishment Labs S.A., Mentor (Johnson & Johnson Medical Ltd), 3M, Zimmer Biomet, Alpha Aesthetics, Symatese, Integra LifeSciences, Sebbin, IDEAL IMPLANT INCORPORATED, Lattice Medical, CEREPLAS, Guangzhou Wanhe Plastic Material Co Ltd, and among others.

5. Which region has the highest share in the Aesthetic implants Market?

North America is expected to dominate the global aesthetic implants market. Factors contributing to the growth are the increasing prevalence of breast cancer and the rise in product launches related to aesthetic implants, which are contributing to the growth of the aesthetic implants market in the North America region.

Table of Contents

1.Aesthetic implants Market Report Introduction

2. Aesthetic implants Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment
• 2.4. Financial Benchmarking

3. Regulatory Analysis

• 3.1. The US
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Aesthetic Implants Market Key Factors Analysis

• 4.1. Aesthetic Implants Market Drivers
  • 4.1.1. Increasing Prevalence of Breast Cancer
  • 4.1.2. Increase in Number of Cosmetic & Reconstructive Surgeries
  • 4.1.3. The rise in the Products Launches & Approvals Related to Aesthetic Implants
  • 4.1.4. Increasing Need for Attractive Physical Appearance
• 4.2. Aesthetic Implants Market Restraints And Challenges
  • 4.2.1. Infections Associated With the Aesthetic Implants
  • 4.2.2. High Cost of Aesthetic Implants
• 4.3. Aesthetic Implants Market Opportunities
  • 4.3.1. 3D Printing Technology in Breast Reconstruction
  • 4.3.2. Increasing Research and Development Activities in Aesthetic Implants
  • 4.3.3. Increasing Awareness about Aesthetic Implants

5. Aesthetic Implants Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Aesthetic Implants Market

7. Aesthetic Implants Market Layout

• 7.1. By Product Type
  • 7.1.1. Breast Implant
  • 7.1.2. Body Contouring Implants
  • 7.1.3. Custom-Made Implants
  • 7.1.4. Nasal Implants
  • 7.1.5. Dental Implants
  • 7.1.6. Others
• 7.2. By Gender
  • 7.2.1. Male
  • 7.2.2. Female
• 7.3. By End-User
  • 7.3.1. Hospitals
  • 7.3.2. Cosmetology Clinics
  • 7.3.3. Ambulatory Surgical Centers
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Aesthetic Implants Market Size in USD Million (2021-2030)
    • 7.4.1.2. Canada Aesthetic Implants Market Size in USD Million (2021-2030)
    • 7.4.1.3. Mexico Aesthetic Implants Market Size in USD Million (2021-2030)
  • 7.4.2. Europe
    • 7.4.2.1. France Aesthetic Implants Market Size in USD Million (2021-2030)
    • 7.4.2.2. Germany Aesthetic Implants Market Size in USD Million (2021-2030)
    • 7.4.2.3. United Kingdom Aesthetic Implants Market Size in USD Million (2021-2030)
    • 7.4.2.4. Italy Aesthetic Implants Market Size in USD Million (2021-2030)
    • 7.4.2.5. Spain Aesthetic Implants Market Size in USD Million (2021-2030)
    • 7.4.2.6. Russia Aesthetic Implants Market Size in USD Million (2021-2030)
    • 7.4.2.7. Rest of Europe Aesthetic Implants Market Size in USD Million (2021-2030)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Aesthetic Implants Market Size in USD Million (2021-2030)
    • 7.4.3.2. Japan Aesthetic Implants Market Size in USD Million (2021-2030)
    • 7.4.3.3. India Aesthetic Implants Market Size in USD Million (2021-2030)
    • 7.4.3.4. Australia Aesthetic Implants Market Size in USD Million (2021-2030)
    • 7.4.3.5. South Korea Aesthetic Implants Market Size in USD Million (2021-2030)
    • 7.4.3.6. Rest of Asia Pacific Aesthetic Implants Market Size in USD Million (2021-2030)
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East Aesthetic Implants Market Size in USD Million (2021-2030)
    • 7.4.4.2. Africa Aesthetic Implants Market Size in USD Million (2021-2030)
    • 7.4.4.3. South America Aesthetic Implants Market Size in USD Million (2021-2030)

8. Aesthetic Implants Market Global Company Share Analysis - Key 3-5 Companies

9. Aesthetic Implants Market Company and Product Profiles

• 9.1. POLYTECH Health & Aesthetics GmbH
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. Sientra Inc
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. Surgiform Innovative Surgical Products
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. GC Aesthetics
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. Dentsply Sirona
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. Institut Straumann AG
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. AVINENT
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. AbbVie
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. Establishment Labs S.A.
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. Mentor (Johnson & Johnson Medical Ltd)
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. 3M
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. Zimmer Biomet
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. Alpha Aesthetics
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.14. Symatese
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy
• 9.15. Integra LifeSciences
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4. Product Listing
  • 9.15.5. Entropy
• 9.16. Sebbin
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4. Product Listing
  • 9.16.5. Entropy
• 9.17. IDEAL IMPLANT INCORPORATED
  • 9.17.1. Company Overview
  • 9.17.2. Company Snapshot
  • 9.17.3. Financial Overview
  • 9.17.4. Product Listing
  • 9.17.5. Entropy
• 9.18. Lattice Medical
  • 9.18.1. Company Overview
  • 9.18.2. Company Snapshot
  • 9.18.3. Financial Overview
  • 9.18.4. Product Listing
  • 9.18.5. Entropy
• 9.19. Guangzhou Wanhe Plastic Material Co Ltd
  • 9.19.1. Company Overview
  • 9.19.2. Company Snapshot
  • 9.19.3. Financial Overview
  • 9.19.4. Product Listing
  • 9.19.5. Entropy
• 9.20. CEREPLAS
  • 9.20.1. Company Overview
  • 9.20.2. Company Snapshot
  • 9.20.3. Financial Overview
  • 9.20.4. Product Listing
  • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us